Zimmer Biomet Holdings Q2 EPS $1.82, Inline, Sales $1.87B Beat $1.82B Estimate
Portfolio Pulse from Benzinga Newsdesk
Zimmer Biomet Holdings (NYSE:ZBH) reported Q2 earnings of $1.82 per share, in line with analyst consensus. The company's quarterly sales of $1.87 billion beat the analyst consensus estimate of $1.82 billion by 2.47 percent, marking a 4.94 percent increase from the same period last year.
August 01, 2023 | 10:38 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Zimmer Biomet's Q2 earnings met expectations and sales exceeded estimates, indicating a positive financial performance.
Zimmer Biomet's earnings were in line with analyst expectations, which is a neutral factor. However, their sales exceeded estimates by 2.47%, which is a positive factor. This indicates a strong financial performance and could lead to a positive reaction in the stock market.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100